The studies presented in the accompanying tables exemplify instances in which the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) applied RWE in regulatory decision-making processes since 2011.
Similar Posts
Real-World Evidence Submissions to the Center for Drug Evaluation and Research
As part of the reauthorization of the Prescription Drug User Fee Act (PDUFA VII), FDA committed to reporting aggregate and anonymized information on submissions.Guangxi Yulin Pharmaceutical Group Co. Ltd. – 710422 – 09/30/2025
CGMP/Finished Pharmaceuticals/AdulteratedEarly Alert: Infusion Pump Issue from Baxter
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramDevalingam Mahalingam, M.D., Ph.D. – 721145 – 12/11/2025
Clinical InvestigatorAnesthesia Kit Recall: Medline Removes Anesthesia Circuits and Anesthesia Circuit Kits
Medline is removing certain anesthesia circuit kits due to cracks and leaks in the tubing.Bruce G. Rankin, DO. DeLand, FL. EIR issued 11/24/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/24/2020
Short Title (70 char) Bruce G. Rankin, DO. DeLand, FL. EIR issued 11/24/2020
FEI Number 3006528394
Firm Name Bruce G. Rankin, DO
Record Type EIR
State FL
Establishment Type Clinical Investigations